Viewing Study NCT06948435


Ignite Creation Date: 2025-12-24 @ 10:08 PM
Ignite Modification Date: 2025-12-30 @ 6:44 AM
Study NCT ID: NCT06948435
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module